KRYSTLE KANE: Open Payments
NPI 1851370209 · POTTSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,730 in 96 payments from 12 companies in 2025. Trend: 2023 $1,990 · 2024 $2,071 · 2025 $1,730
Food & beverage: $1,634Education: $96
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $413 |
| Regeneron Healthcare Solutions, Inc. | 6 | $216 |
| Janssen Biotech, Inc. | 15 | $214 |
| Novartis Pharmaceuticals Corporation | 12 | $203 |
| GENZYME CORPORATION | 8 | $169 |
| Galderma Laboratories, L.P. | 6 | $133 |
| Lilly USA, LLC | 6 | $130 |
| Amgen Inc. | 6 | $109 |
| UCB, Inc. | 2 | $55 |
| Organon LLC | 2 | $33 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, COSENTYX, NEMLUVIO, TALTZ, Otezla, Bimzelx.
Industry payments across PA — which companies pay providers there.
